Hyperaldosteronism after heart surgery in children. Part I: Treatment with aldosterone antagonists

Padiatrie Und Padologie
|January 1, 1981
PubMed

Insights

Postoperative hyperaldosteronism in children undergoing heart surgery leads to body potassium loss. Aldosterone antagonists did not alter this effect or reduce potassium depletion.

Area of Science:

  • Pediatric Surgery
  • Endocrinology
  • Cardiovascular Surgery

Background:

  • Postoperative hyperaldosteronism is a potential complication following cardiac surgery in children.
  • Fluid and electrolyte imbalances, particularly potassium loss, can occur in the postoperative period.

Purpose of the Study:

  • To investigate the effects of postoperative hyperaldosteronism on fluid and electrolyte metabolism in pediatric cardiac surgery patients.
  • To evaluate the efficacy of aldosterone antagonists in mitigating these effects.

Main Methods:

  • Studied serum and red cell electrolytes (sodium, potassium) and hematocrit in children post-heart surgery.
  • Compared open versus closed heart surgery outcomes.
  • Administered aldosterone antagonists preoperatively to a subset of open heart surgery patients.

Main Results:

  • Transient hyponatremia and persistent hypokalemia were observed, indicating body potassium loss.
  • No significant differences in electrolyte changes between open and closed heart surgery groups.
  • Aldosterone antagonists did not alter the course or extent of hyperaldosteronism or prevent potassium loss.

Conclusions:

  • Postoperative hyperaldosteronism in pediatric cardiac surgery patients is associated with significant potassium loss.
  • The aldosterone antagonists tested, at the dosages used, were ineffective in altering the course of hyperaldosteronism or preventing potassium loss.

Related Concept Videos

Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...